论文部分内容阅读
目的探讨儿童肺炎支原体肺炎的诊断特点及治疗方案,提高对小儿肺炎支原体(MP)肺炎的临床认识和诊治水平。方法对商丘市第三人民医院2013年1月至2013年12月间收治的60例儿童支原体肺炎患者的临床特点进行总结和分析。结果发病年龄多为较大儿童,4~14岁占49.9%,咳嗽病例42例,占70.0%,发热病例36例,占60.0%,早期血清MP-Ig M检测结果显示阳性者占88.7%,X线检查均表现为肺门阴影增浓,但存在不同的病变特点。经大环内酯类药物治疗后,治愈55例(91.7%),显效,5例(8.3%),平均住院时间(10.2±2.6)d。结论儿童肺炎支原体肺炎行MP-Ig M检测阳性率较高,早期应用大环内酯类药物疗效好。
Objective To investigate the diagnosis and treatment of Mycoplasma pneumoniae pneumonia in children and improve the clinical knowledge and diagnosis and treatment of children with Mycoplasma pneumoniae (MP) pneumonia. Methods The clinical features of 60 children with mycoplasma pneumonia admitted from January 2013 to December 2013 in Shangqiu Third People’s Hospital were summarized and analyzed. Results Most of the patients were older, 49.9% were from 4 to 14 years old, 42 cases were cough (70.0%), 36 cases were fever (60.0%), 88.7% were positive from early serum MP-Ig M test, X-ray examination showed hilar shadow thickening, but there are different pathological features. After macrolide treatment, 55 cases (91.7%) were cured, 5 cases (8.3%) were cured, and the average hospital stay was (10.2 ± 2.6) days. Conclusion The positive rate of MP-Ig M in children with Mycoplasma pneumoniae pneumonia is high, and the early use of macrolides is effective.